RIBOCICLIB vs RIFAMPIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RIBOCICLIB vs RIFAMPIN: Safety Overview
| Metric | RIBOCICLIB | RIFAMPIN |
|---|---|---|
| Total FAERS Reports | 27,997 | 13,347 |
| Deaths Reported | 4,501 | 1,439 |
| Death Rate | 16.1% | 10.8% |
| Hospitalizations | 6,700 | 5,764 |
| Average Patient Age | 60.2 yrs | 51.7 yrs |
| % Female Patients | 99.0% | 47.8% |
| FDA Approval Date | Mar 13, 2017 | Approved Prior to Jan 1, 1982 |
| Manufacturer | Novartis Pharmaceuticals Corporation | Hikma Pharmaceuticals USA Inc. |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | Discontinued |